| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |